In 2024, Zhejiang Huahai Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 |
|---|---|
Total Waste Generated | 92,384a |
Total Waste Recovered | 12,902a |
Total Hazardous Waste Generated | 87,383a |
Non-Hazardous Waste Disposed | 1,904a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, Zhejiang Huahai Pharmaceutical generated a total of 92,384metric tonnes of waste.a
Of this amount, 13.97% of Zhejiang Huahai Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 86.03% was disposed of through landfilling, incineration, or combustion.a
In 2024, Zhejiang Huahai Pharmaceutical reported a total waste generation of 92,384 metric tonnes, of which 13.97% was recovered through recycling, reuse, or composting.This low recovery rate highlights limited waste diversion and suggests that Zhejiang Huahai Pharmaceutical may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.a
In 2024, Zhejiang Huahai Pharmaceutical generated a total of 92,384 metric tonnes of waste.a
Of this amount, 94.59% of Zhejiang Huahai Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.5.41% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
In 2024, Zhejiang Huahai Pharmaceutical reported that 87,383 metric tonnes of its total waste output were classified as hazardous. This represents 94.59% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Approximately 11.22% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a